FOURTH AMENDMENT TO THE AMENDED AND RESTATED DISTRIBUTION RIGHTS AGREEMENTDistribution Rights Agreement • February 26th, 2010 • Biovail Corp International • Pharmaceutical preparations • New York
This FOURTH AMENDMENT TO AMENDED AND RESTATED DISTRIBUTION RIGHTS AGREEMENT (the “Fourth Amendment”) is made effective as of this 21st day of November, 2008, by and between Biovail Laboratories International SRL, a Barbados International Society with Restricted Liability and having a principal place of business at Welches, Christ Church, Barbados, West Indies (“Biovail”), and SmithKline Beecham Corporation, a GlaxoSmithKline company, a corporation duly organized and existing under the applicable laws of the Commonwealth of Pennsylvania and having a principal place of business at One Franklin Plaza, Philadelphia, PA 19101 (“GSK”). Biovail and GSK are collectively referred to in this Fourth Amendment as the “Parties” and individually as a ‘Party.”
Biovail Laboratories International SRL Welches, Christ Church Barbados, West Indies BB17154Distribution Rights Agreement • February 26th, 2010 • Biovail Corp International • Pharmaceutical preparations • New York
This letter (the “Fifth Amendment”), to be effective as of the date set forth above, is in reference to that certain Amended and Restated Distribution Rights Agreement, effective as of October 26, 2001, as amended by the First Amendment to the Amended and Restated Distribution Rights Agreement, effective as of May 1, 2005, the Second Amendment to the Amended and Restated Distribution Rights Agreement, effective as of October 12, 2005, the Third Amendment to the Amended and Restated Distribution Rights Agreement, effective as of December 18, 2006, and the Fourth Amendment to the Amended and Restated Distribution Rights Agreement, effective as of November 21, 2008 (collectively, the “Zovirax Agreement”), between Biovail Laboratories International SRL (“Biovail”) and SmithKline Beecham Corporation (“GSK”). Capitalized terms used herein but not otherwise defined shall have the meanings set forth in the Zovirax Agreement.
CONFIDENTIAL TREATMENT REQUESTED: Portions of this Exhibit have been redacted pursuant to a request for confidential treatment under Rule 24b-2 of the General Rules and Regulations under the Securities Exchange Act of 1934, as amended. Such redacted...Distribution Rights Agreement • February 26th, 2010 • Biovail Corp International • Pharmaceutical preparations • New York
This THIRD AMENDMENT TO AMENDED AND RESTATED DISTRIBUTION RIGHTS AGREEMENT (the “Third Amendment”) is made effective as of this 18th day of December, 2006, by and between Biovail Laboratories International SRL, a Barbados International Society with Restricted Liability and having a principal place of business at Chelston Park, Building 2, Collymore Rock, St. Michael, BH1, Barbados, W.I. (“Biovail”), and SmithKline Beecham Corporation, a GlaxoSmithKline company, a corporation duly organized and existing under the applicable laws of the Commonwealth of Pennsylvania and having a principal place of business at One Franklin Plaza, Philadelphia, PA 19101 (“GSK”). Biovail and GSK are collectively referred to in this Third Amendment as the “Parties” and individually as a “Party.”
CONFIDENTIAL FIRST AMENDMENT TO THE DISTRIBUTION RIGHTS AGREEMENTDistribution Rights Agreement • March 11th, 2004 • Plug Power Inc • Electrical industrial apparatus
THIS FIRST AMENDMENT TO THE DISTRIBUTOR RIGHTS AGREEMENT (the “Amendment”) is made and entered into effective as of this 2nd day of July, 2003, between Plug Power Inc., a Delaware corporation (“PP”), and GE Fuel Cell Systems, L.L.C., a Delaware limited liability company (“GEFCS”). GEFCS and PP are referred to individually herein as a “Party”, and collectively as the “Parties”.
Distribution Rights Agreement for Tyvaso®, a Treatment for Pulmonary Arterial Hypertension, in JapanDistribution Rights Agreement • March 28th, 2017
This material is an English translation of the press release issued on March 28, 2017 in Japanese, and the Japanese release is given priority regarding content and interpretation.
CONFIDENTIAL TREATMENT REQUESTED: Portions of this Exhibit have been redacted pursuant to a request for confidential treatment under Rule 24b-2 of the General Rules and Regulations under the Securities Exchange Act of 1934, as amended. Such redacted...Distribution Rights Agreement • February 26th, 2010 • Biovail Corp International • Pharmaceutical preparations • New York
This SECOND AMENDMENT TO AMENDED AND RESTATED DISTRIBUTION RIGHTS AGREEMENT (the “Second Amendment”) is made effective as of this 12 day of October, 2005, by and between Biovail Laboratories International SRL, a Barbados International Society with Restricted Liability and having a principal place of business at Chelston Park, Building 2, Collymore Rock, St. Michael, BH1, Barbados, WI (“Biovail”), and SmithKline Beecham Corporation, a GlaxoSrnithKline company, a corporation duly organized and existing under the applicable laws of the Commonwealth of Pennsylvania and having a principal place of business at One Franklin Plaza, Philadelphia, PA 19101 (“GSK”). Biovail and GSK are collectively referred to in this Second Amendment as the “Parties” and individually as a “Party.”
SIXTH AMENDMENT TO THE AMENDED AND RESTATED DISTRIBUTION RIGHTS AGREEMENTDistribution Rights Agreement • February 26th, 2010 • Biovail Corp International • Pharmaceutical preparations • New York
THIS SIXTH AMENDMENT TO THE AMENDED AND RESTATED DISTRIBUTION RIGHTS AGREEMENT (the “Sixth Amendment”) is made effective as of this 16th day of September, 2009 by and between Biovail Laboratories International SRL, a Barbados International Society with Restricted Liability and having a principal place of business at Welches, Christ Church, BB17154, Barbados, West Indies (“Biovail”) and SmithKline Beecham Corporation, a GlaxoSmithKline company, a corporation duly organized and existing under the applicable laws of the Commonwealth of Pennsylvania having a principal place of business at One Franklin Plaza, Philadelphia, PA 19102 (“GSK”). GSK and Biovail are collectively referred to in this Sixth Amendment as “Parties” and individually as a “Party”.
SEVENTH AMENDMENT TO THE AMENDED AND RESTATED DISTRIBUTION RIGHTS AGREEMENTDistribution Rights Agreement • February 26th, 2010 • Biovail Corp International • Pharmaceutical preparations • New York
THIS SEVENTH AMENDMENT TO AMENDED AND RESTATED DISTRIBUTION RIGHTS AGREEMENT (the “Seventh Amendment”) is made effective as of this day of November, 2009 by and between Biovail Laboratories International SRL, a Barbados International Society with Restricted Liability and having a principal place of business at Welches, Christ Church, Barbados, BB17154, West Indies (“Biovail”) and SmithKline Beecham Corporation, a GlaxoSmithKline company, a corporation duly organized and existing under the applicable laws of the Commonwealth of Pennsylvania having a principal place of business at One Franklin Plaza, Philadelphia, PA 19102 (“GSK”). GSK and Biovail are collectively referred to in this Seventh Amendment as “Parties” and individually as a “Party”.
EXHIBIT 10.7 INTERNATIONAL DISTRIBUTION RIGHTS AGREEMENT THIS AGREEMENT is entered into this ____ day of _____________, 2000 and is to replace and supersede all form agreements, if any, both verbal and/or written: BETWEEN: Advanced Knowledge, Inc....Distribution Rights Agreement • January 16th, 2001 • Becor Communications Inc • Services-personal services • California
DISTRIBUTION RIGHTS AGREEMENTDistribution Rights Agreement • June 29th, 2005 • Rg Global Lifestyles Inc • Dolls & stuffed toys
THIS AGREEMENT, made this 1st day of July 2004 by and between PT Pacific Image Internasional (First Party) and Amerikal Nutraceutical Corporation (Second Party)
EXHIBIT 10.31 DISTRIBUTION RIGHTS AGREEMENT ----------------------------- Parties: RAVISENT Technologies Internet Appliance ------- Group, Inc. d/b/a RAVISENT Technologies ("RAVISENT") a Delaware corporation 173 1 Technology Drive San Jose. CA 95110...Distribution Rights Agreement • August 14th, 2000 • Ravisent Technologies Inc • Services-prepackaged software • California
